Family Medicine · Wytheville, VA
NPI
1770563496
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
1375 W Ridge Rd
Wytheville, VA, 24382
Phone (276) 228-8686
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.7M
15,882 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Kari L Thomas prescribed most often to Medicare patients was Gabapentin, with 764 prescriptions and refills. In total Kari L Thomas wrote 15,882 Medicare prescriptions that cost $1.7M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Gabapentin Generic | 764 | 840 | 137 | $14K |
| Atorvastatin Calcium Generic | 489 | 1,108 | 125 | $3,960 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 418 | 418 | 54 | $15K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 403 | 531 | 100 | $11K |
| Levothyroxine Sodium Generic | 401 | 951 | 98 | $3,586 |
| Furosemide Generic | 386 | 854 | 111 | $1,649 |
| Pregabalin Generic | 362 | 371 | 68 | $8,060 |
| Lisinopril Generic | 357 | 895 | 95 | $2,293 |
| Omeprazole Generic | 325 | 815 | 85 | $4,635 |
| Metformin Hcl Generic | 281 | 723 | 80 | $2,138 |
| Pantoprazole Sodium Generic | 279 | 680 | 87 | $2,729 |
| Alprazolam Generic | 263 | 270 | 37 | $1,187 |
| Trazodone Hcl Generic | 240 | 480 | 64 | $2,625 |
| Duloxetine Hcl Generic | 221 | 508 | 55 | $6,304 |
| Meloxicam Generic | 220 | 474 | 63 | $1,010 |
Brand drugs: 2,155 claims; generic drugs: 13,667 claims; opioid claims: 643.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Kari L Thomas were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.